Stock price when the opinion was issued
Wait for a pullback, given current highs. As Canada's economy softens, more shoppers spend at their discount banners. Shoppers are doing very well in beauty goods as they get out of the low-margin electronics; many provinces are allowing pharmacists to expand their role, which is another tailwind for Shoppers Drug Mart (that Loblaw owns). They are expanding their margins and guiding higher.
Has held in remarkably well; considered a defensive name when markets turn volatile with risk of economic slowdown. Traffic gravitated to its discount banners. Pharmacists' roles have expanded at SDM, which also helps drive traffic. Plans to open more pharmacy-based clinics across Canada. Executing very well. Not inexpensive at 22x forward PE, wait for a pullback.
Depends where you own it. If in a taxable account and you have to pay capital gains, he'd say no. If it's in a registered account, it becomes a very good question, and he'd say yes.
It was on its back forever, and look at it now. There's a lesson for all investors: a lot of stocks take their time to shine. Still has a 10% growth rate, trades at 22x PE (kind of expensive, but WMT trades at 33x and COST at 45x). He thinks the whole space is pricey, and he'd put $$ into other areas.
Likes its positioning in food retail and its pharmaceutical business. Expansion of pharmacists' duties is helping traffic. Discount banners have really been benefiting from softness in the economy, and they have plans to expand the discount footprint. Acquisition of TNT, an Asian chain, is going well.
Food retailing is defensive. Unlike Empire, Loblaw owns Shoppers which gives it an edge. Loblaw is expanding their health business, entering digital health with a new acquisition. The locations of both Loblaw and SDM are great and boast a 30% market share. People are becoming comfortable using online medical services, a trend that will continue across North America long term. The growth rate in their click-and-collect and grocery delivery may not be that strong, but will continue to rise. Trades at 14x forward earnings, reasonable. The dividend is a moderate 2%. Even if we enter high volatility, this sector and stock will be fine. (Analysts’ price target is $80.82)